News

April 22, 2025

We are proud to announce that ExploRNA Therapeutics has gained ISO 9001:2015 Certification from LL-C (Certification) for its quality management system, applicable to the production and sale of nucleotides, nucleic acids, and their derivatives. ISO 9001 is a globally...

March 3, 2025

We are moments away from the RNA Leaders Europe Congress in Basel. It is a perfect opportunity to talk to Tomasz Piec and Piotr Stępniak about our new cap analogs. Find out more and get inspired to create better...

February 28, 2025

Our CEO, prof. Jacek Jemielity was invited to give a seminar at the RNA Therapeutics Institute at UMass Chan Medical School. We are very proud for our leader to be recognised by the top RNA scientists in the world....

October 2, 2024

We are proud to announce that our Director of Business Development, Piotr Stępniak, will have the honor to speak at the Polish Embassy at a special event organised to promote Polish innovative biotechnology sector in front of esteemed guests...

September 3, 2024

San Diego, CA, USA and Warsaw, Poland – September 3, 2024 – Primrose Bio, a leading biotechnology company specializing in technologies that improve the manufacturing of next-generation therapeutics, and ExPLoRNA Therapeutics, a pioneering biotechnology company advancing mRNA technologies, vaccines,...

August 22, 2024

The Polish Healthcare Assets – Sector Event (PHASE) quickly became the Polish largest public discussion about medical biotechnology. It brings together industry leaders, venture capital, public institutions, and scientists, all debating the development of the sector. During this year’s...

March 8, 2024

We are happy to share that our most recent work has been featured in the Journal of American Chemical Society. This has been a great collaboration with University of Warsaw and we’d like to thank our partners and team...

February 28, 2024

We are happy to join forces with the industry leaders working to better mRNA medicines, increase their accessibility, and educate patients and their families about mRNA and how it works in therapies and vaccines. prof. Dominika Nowis, our Director...

August 16, 2023

Meet our CEO prof. Jacek Jemielity among other Polish innovators at the Polish Healthcare Assets Sector Event. Prof. Jemielity will take part in a panel discussing how technology invented and developed in Poland can change the global Life Science...